Human medicines European public assessment report (EPAR): Pixuvri, pixantrone dimaleate, Date of authorisation: 10/05/2012, Revision: 23, Status: Expired

This medicine’s product information is available in all official EU languages.
Select 'available languages' to access the language you need.

Product information documents contain:

summary of product characteristics (annex I);
manufacturing authorisation holder responsible for batch release (annex IIA);
conditions of the marketing authorisation (annex IIB);
labelling (annex IIIA);
package leaflet (annex IIIB).

You just read:

Human medicines European public assessment report (EPAR): Pixuvri, pixantrone dimaleate, Date of authorisation: 10/05/2012, Revision: 23, Status: Expired

Distribution channels: Healthcare & Pharmaceuticals Industry

EIN Presswire's priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content. As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone's Internet News Presswire™, tries to define some of the boundaries that are reasonable in today's world. Please see our Editorial Guidelines for more information.